HDAC6 at Crossroads of Infection and Innate Immunity

被引:36
|
作者
Moreno-Gonzalo, Olga [1 ,2 ]
Mayor, Federico, Jr. [3 ,4 ]
Sanchez-Madrid, Francisco [1 ,2 ,4 ]
机构
[1] CNIC, Vasc Pathophysiol Area, Cell Cell Commun Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Inst Invest Sanit La Princesa IIS IP, Hosp Univ Princesa, Serv Inmunol, Diego Leon 62, Madrid 28006, Spain
[3] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Dept Biol Mol, E-28049 Madrid, Spain
[4] ISCIII CIBERCV, CIBER Enfermedades Cardiovasc, Madrid 28029, Spain
关键词
D O I
10.1016/j.it.2018.05.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Histone deacetylase 6 (HDAC6) acts by enzyme-dependent and-independent mechanisms to regulate diverse cellular processes including autophagy, the ubiquitin proteasome system, and cell migration. HDAC6 also has emerging roles in innate immunity, including pathogen sensing and destruction, thus placing this enzyme at the crossroads of infection and innate immunity.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 50 条
  • [21] HDAC6 score: to treat or not to treat?
    Joschka Hey
    Maria Llamazares Prada
    Christoph Plass
    Nature Cancer, 2023, 4 : 156 - 158
  • [22] QSAR Analysis of HDAC6 Inhibitors
    O. V. Tinkov
    V. Yu. Grigorev
    L. D. Grigoreva
    Moscow University Chemistry Bulletin, 2022, 77 : S25 - S35
  • [23] HDAC6: A unique HDAC family member as a cancer target
    Sumeet Kaur
    Prerna Rajoria
    Madhu Chopra
    Cellular Oncology, 2022, 45 : 779 - 829
  • [24] A role for HDAC6 in leptin sensitivity
    Claire Greenhill
    Nature Reviews Endocrinology, 2022, 18 : 194 - 194
  • [25] HDAC6: A unique HDAC family member as a cancer target
    Kaur, Sumeet
    Rajoria, Prerna
    Chopra, Madhu
    CELLULAR ONCOLOGY, 2022, 45 (05) : 779 - 829
  • [26] SET7 interacts with HDAC6 and suppresses the development of colon cancer through inactivation of HDAC6
    Zhang, Shi-Lan
    Du, Xiao
    Tan, Lin-Na
    Deng, Fei-Hong
    Zhou, Bing-Yi
    Zhou, He-Jun
    Zhu, Hong-Yi
    Chu, Yi
    Liu, De-Liang
    Tan, Yu-Yong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (02): : 602 - 611
  • [27] Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis in vivo: A Role for HDAC6 Neddylation
    Nomura, Yohei
    Nakano, Mitsunori
    Woo Sung, Hyun
    Han, Mingming
    Pandey, Deepesh
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [28] Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation
    Lin, Ching
    Hsu, Jui-Ling
    Hsu, Yu-Tung
    Fan, Kuo-Chen
    Wu, Sian-Siou
    Lin, Miao-Hsia
    Guh, Jih-Hwa
    Yu, Chao-Wu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [29] The role of histone deacetylase 6 (HDAC6) in neurodegeneration
    Van Helleputte, Lawrence
    Benoy, Veronick
    Van Den Bosch, Ludo
    RESEARCH AND REPORTS IN BIOLOGY, 2014, 5 : 1 - 13
  • [30] Notch signaling at the crossroads of innate and adaptive immunity
    Vanderbeck, Ashley
    Maillard, Ivan
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 109 (03) : 535 - 548